Triamcinolone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Triamcinolone. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 51% |
| Pharyngitis | 13.7% |
| Back pain | 7.8% |
| Taste perversion | 7.8% |
| Asthma | 5.4% |
| Dyspepsia | 4.9% |
| Conjunctivitis | 4.4% |
| Myalgia | 3.3% |
| Nausea | 3% |
| Cough increased | 2.7% |
| Vomiting | 2.7% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
AllerNaze is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 12 years of age or older.
Source: FDA labeling via NIH DailyMed (set dbdc8273…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.